Osteoporosis: Nonclinical Evaluation of Drugs Intended for Treatment Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 15, 2019
May 15, 2020
8305ef9e-7edf-412b-bb46-28ef3a7f9493
Related Documents
Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
Guidance DocumentAugust 2, 2019Center for Drug Evaluation and Research
Investigational Enzyme Replacement Therapy Products: Nonclinical Assessment: Guidance for Industry
Guidance DocumentOctober 3, 2019Center for Drug Evaluation and Research
Vulvovaginal Candidiasis: Developing Drugs for Treatment
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox